This Article Full Text Full Text (PDF) All Versions of this Article: 53/2_Part_2/399    most recent HYPERTENSIONAHA.108.123513v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Gilbert, J. S. Articles by Granger, J. P. Search for Related Content PubMed PubMed Citation Articles by Gilbert, J. S. Articles by Granger, J. P. Related Collections Animal models of human disease Other hypertension Other Vascular biology

(Hypertension. 2009;53:399.)
© 2009 American Heart Association, Inc.

Original Articles Part 2

Hypertension Produced by Placental Ischemia in Pregnant Rats Is Associated With Increased Soluble Endoglin Expression

From the Department of Physiology and Center for Excellence in Cardiovascular-Renal Research (J.S.G., S.A.B.G., M.A., J.P.G.), University of Mississippi Medical Center, Jackson. Current address (J.S.G., S.A.B.G.): Department of Physiology and Pharmacology, University of Minnesota Medical School, Duluth, Minn.

Correspondence to Joey P. Granger, Department of Physiology and Biophysics, University of Mississippi Medical Center, 2500 N State St, Jackson, MS 39216-4505. E-mail jgranger{at}physiology.umsmed.edu

Recent clinical studies indicate that an excess of angiostatic factors, such as soluble endoglin (sEng), is related to the occurrence of preeclampsia. Although recent clinical studies report that sEng is increased in preeclamptic women, the mechanisms underlying its overexpression remain unclear. Evidence suggests that hypoxia and induction of heme oxygenase-1 have opposing effects on sEng expression, the former stimulatory and the latter inhibitory. Hence, we hypothesized that placental ischemia because of reduced uterine perfusion pressure (RUPP) in the pregnant rat would increase sEng expression and decrease heme oxygenase-1. Mean arterial pressure was obtained via arterial catheter, and serum and placental proteins were measured by Western blot. Mean arterial pressure was increased (132±3 mm Hg versus 102±2 mm Hg; P<0.001), and fetal (2.35±0.05 g versus 1.76±0.08 g; P<0.001) and placental weight were decreased (0.47±0.04 g versus 0.58±0.03 g; P<0.01) in the RUPP compared with normal pregnant controls. Serum sEng (0.10±0.02 arbitrary pixel units [apu] versus 0.05±0.01 apu; P<0.05) and placental endoglin (4.7±2.3 apu versus 1.45±0.42 apu; P<0.05) were increased along with placental hypoxia inducible factor-1 (1.42±0.25 apu versus 0.68±0.09 apu; P<0.05) expression in the RUPP versus the normal pregnant dams. Placental HO-1 (1.4±0.3 apu versus 2.5±0.1 apu; P<0.05) expression decreased in the RUPP compared with normal pregnant dams. The present findings support our hypothesis that placental ischemia because of RUPP increases the expression of sEng and shifts the balance of angiogenic factors in the maternal circulation toward an angiostatic state. The present study provides further evidence that placental ischemia is a strong in vivo stimulus of angiostatic factors during pregnancy.

Key Words: preeclampsia • gestation • endoglin • blood pressure